Michael Allison

14.9k total citations · 5 hit papers
108 papers, 6.4k citations indexed

About

Michael Allison is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Michael Allison has authored 108 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Epidemiology, 40 papers in Hepatology and 26 papers in Surgery. Recurrent topics in Michael Allison's work include Liver Disease Diagnosis and Treatment (48 papers), Liver Disease and Transplantation (32 papers) and Organ Transplantation Techniques and Outcomes (20 papers). Michael Allison is often cited by papers focused on Liver Disease Diagnosis and Treatment (48 papers), Liver Disease and Transplantation (32 papers) and Organ Transplantation Techniques and Outcomes (20 papers). Michael Allison collaborates with scholars based in United Kingdom, United States and Italy. Michael Allison's co-authors include Douglas T. Fearon, Christopher C. Goodnow, Paul W. Dempsey, Quentin M. Anstee, Graeme Alexander, Tim Wreghitt, Chris Palmer, Antonio Vidal‐Puig, Michèle Vacca and Emmanuel Tsochatzis and has published in prestigious journals such as Nature, Science and The Lancet.

In The Last Decade

Michael Allison

104 papers receiving 6.2k citations

Hit Papers

C3d of Complement as a Mo... 1996 2026 2006 2016 1996 2019 2014 2020 2024 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity
    1996 941 citations Michael Allison et al. profile →
  2. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
    2019 930 citations Peter Eddowes, M. Sasso et al. Gastroenterology profile →
  3. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
    2014 454 citations Stuart McPherson, Michael Allison et al. profile →
  4. Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease
    2020 237 citations Vian Azzu, Michèle Vacca et al. Gastroenterology profile →
  5. Acquisition of epithelial plasticity in human chronic liver disease
    2024 44 citations Christopher Gribben, Vasileios Galanakis et al. Nature profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Michael Allison 3.2k 2.0k 1.2k 1.0k 954 108 6.4k
Roger Williams 2.8k 0.9× 3.5k 1.7× 2.4k 2.0× 385 0.4× 306 0.3× 259 8.8k
David P. Ryan 2.9k 0.9× 1.2k 0.6× 3.6k 3.0× 739 0.7× 192 0.2× 423 17.1k
Jeffrey W. Clark 2.4k 0.8× 1.7k 0.8× 2.4k 2.0× 2.2k 2.1× 220 0.2× 351 16.8k
Francesco Izzo 2.4k 0.7× 4.4k 2.2× 2.0k 1.7× 387 0.4× 177 0.2× 268 9.6k
Adam C. Yopp 3.8k 1.2× 4.0k 1.9× 2.3k 1.9× 1.2k 1.2× 205 0.2× 217 10.0k
Lauren Grace Mackey 5.3k 1.6× 5.6k 2.7× 5.9k 4.9× 3.6k 3.5× 3.1k 3.2× 450 18.6k
Teresa L. Wright 12.9k 4.0× 11.6k 5.7× 1.8k 1.5× 815 0.8× 162 0.2× 224 17.2k
William D. Carey 4.9k 1.5× 5.1k 2.5× 2.2k 1.9× 180 0.2× 220 0.2× 177 7.8k
Roger B. Cohen 1.2k 0.4× 409 0.2× 3.4k 2.8× 1.6k 1.5× 825 0.9× 328 17.5k
Paul Ruff 779 0.2× 1.8k 0.9× 1.3k 1.1× 322 0.3× 123 0.1× 155 8.9k

Countries citing papers authored by Michael Allison

Since Specialization
Citations

This map shows the geographic impact of Michael Allison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Allison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Allison more than expected).

Fields of papers citing papers by Michael Allison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Allison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Allison. The network helps show where Michael Allison may publish in the future.

Co-authorship network of co-authors of Michael Allison

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Allison. A scholar is included among the top collaborators of Michael Allison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Allison. Michael Allison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parker, Richard, Guruprasad P. Aithal, Michael Allison, et al.. (2025). Defining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver Disease. The American Journal of Gastroenterology.
2.
Gribben, Christopher, Vasileios Galanakis, Alexander Calderwood, et al.. (2024). Acquisition of epithelial plasticity in human chronic liver disease. Nature. 630(8015). 166–173. 44 indexed citations breakdown →
3.
4.
Mocciaro, Gabriele, Michael Allison, Mattia Frontini, et al.. (2024). Oxidised serum peptidome characterises metabolic dysfunction-associated steatotic liver disease.. Atherosclerosis. 395. 117863–117863. 1 indexed citations
5.
Aithal, Guruprasad P., Michael Allison, Mayur Brahmania, et al.. (2023). Extra‐hepatic morbidity and mortality in alcohol‐related liver disease: Systematic review and meta‐analysis. Liver International. 43(4). 763–772. 16 indexed citations
6.
Madden, Angela, Fumiaki Imamura, Danielle Jones, et al.. (2023). Nutritional Intake after Liver Transplant: Systematic Review and Meta-Analysis. Nutrients. 15(11). 2487–2487. 2 indexed citations
7.
Mocciaro, Gabriele, Michael Allison, Benjamin Jenkins, et al.. (2023). Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL). Molecular Metabolism. 73. 101728–101728. 33 indexed citations
8.
Brüggenwirth, Isabel M.A., Maureen J. M. Werner, René Adam, et al.. (2021). The Liver Retransplantation Risk Score: a prognostic model for survival after adult liver retransplantation. Transplant International. 34(10). 1928–1937. 11 indexed citations
9.
10.
11.
Azzu, Vian, Michèle Vacca, Sam Virtue, Michael Allison, & Antonio Vidal‐Puig. (2020). Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease. Gastroenterology. 158(7). 1899–1912. 237 indexed citations breakdown →
12.
Hall, Zoe, Davide Chiarugi, Evelina Charidemou, et al.. (2020). Lipid Remodeling in Hepatocyte Proliferation and Hepatocellular Carcinoma. Hepatology. 73(3). 1028–1044. 101 indexed citations
13.
Forrest, Ewan, Rohit Sinha, Stephen R. Atkinson, et al.. (2019). Baseline neutrophil‐to‐lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitis. Alimentary Pharmacology & Therapeutics. 50(4). 442–453. 48 indexed citations
14.
Eddowes, Peter, M. Sasso, Michael Allison, et al.. (2019). Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 156(6). 1717–1730. 930 indexed citations breakdown →
15.
Sheridan, David, Guruprasad P. Aithal, William Alazawi, et al.. (2017). Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional survey. Frontline Gastroenterology. 8(4). 252–259. 24 indexed citations
16.
Hall, Zoe, Nicholas J. Bond, Tom Ashmore, et al.. (2016). Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease. Hepatology. 65(4). 1165–1180. 151 indexed citations
17.
Watson, Christopher J.E., Alexander Gimson, Graeme J.M. Alexander, et al.. (2007). A Randomized Controlled Trial of Late Conversion From Calcineurin Inhibitor (CNI)-Based to Sirolimus-Based Immunosuppression in Liver Transplant Recipients with Impaired Renal Function. Liver Transplantation. 13(12). 1694–1702. 76 indexed citations
18.
Roberts, Rebecca, Antonia C. Wells, Esther Unitt, et al.. (2007). Sirolimus-Induced Pneumonitis Following Liver Transplantation. Liver Transplantation. 13(6). 853–856. 22 indexed citations
19.
Nash, Kathryn, Michael Allison, Damian McKeon, et al.. (2007). A single centre experience of liver disease in adults with cystic fibrosis 1995–2006. Journal of Cystic Fibrosis. 7(3). 252–257. 48 indexed citations
20.
Canache, Damarys & Michael Allison. (2005). Perceptions of Political Corruption in Latin American Democracies. Latin American Politics and Society. 47(3). 91–111. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roger Williams Breakdown of academic impact, for papers by David P. Ryan Breakdown of academic impact, for papers by Jeffrey W. Clark Breakdown of academic impact, for papers by Francesco Izzo Breakdown of academic impact, for papers by Adam C. Yopp Breakdown of academic impact, for papers by Lauren Grace Mackey Breakdown of academic impact, for papers by Teresa L. Wright Breakdown of academic impact, for papers by William D. Carey Breakdown of academic impact, for papers by Roger B. Cohen Breakdown of academic impact, for papers by Paul Ruff
Rankless by CCL
2026